雜志介紹

Eclinicalmedicine雜志介紹

《Eclinicalmedicine》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱臨床醫(yī)學，本刊主要出版、報道醫(yī)學-MEDICINE, GENERAL & INTERNAL領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為9.6，最新CiteScore 指數(shù)為18.9。

本刊近期中國學者發(fā)表的論文主要有：

• CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn?s disease: a multicentre cohort study

  Author: Li, Xuehua; Zhang, Naiwen; Hu, Cicong; Lin, Yuqin; Li, Jiaqiang; Li, Zhoulei; Cui, Enming; Shi, Li; Zhuang, Xiaozhao; Li, Jianpeng; Lu, Jiahang; Wang, Yangdi; Liu, Renyi; Yuan, Chenglang; Lin, Haiwei; He, Jinshen; Ke, Dongping; Tang, Shanshan; Zou, Yujian; He, Bo; Sun, Canhui; Chen, Minhu; Huang, Bingsheng; Mao, Ren; Feng, Shi-Ting

• Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial

  Author: Zhu, Xiaofei; Liu, Wenyu; Cao, Yangsen; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Zhang, Huojun

• Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study

  Author: Yang, Aimin; Shi, Mai; Lau, Eric S. H.; Wu, Hongjiang; Zhang, Xinge; Fan, Baoqi; Kong, Alice P. S.; Luk, Andrea O. Y.; Ma, Ronald C. W.; Chan, Juliana C. N.; Chow, Elaine

• Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial

  Author: Tittanegro, Thais; China, Louise; Forrest, Ewan; Kallis, Yiannis; Ryder, Stephen D.; Wright, Gavin; Freemantle, Nick; O'Brien, Alastair

英文介紹

Eclinicalmedicine雜志英文介紹

eClinicalMedicine covers clinical research from all medical specialties—from diagnosis to treatment, prevention to palliative care, and health promotion to health policy and equity. We aim to help frontline health professionals navigate the complex and rapid health transitions facing societies worldwide and aspire to be a catalyst to rethink and reframe the future of health and health care with the ultimate goal of strengthening health systems as core institutions.As a popular journal among medical professionals worldwide, it helps them improve the quality and efficiency of healthcare services by providing the latest medical research findings and clinical practice guidelines.